Cumulatively, it was identified that I3C attenuated acute colitis through activating AhR, improving gut microbiota and mitigating inflammation, whereas DIM inhibited inflammation and angiogenesis, revealing that both I3C and DIM can be considered as a potential agent against colitis. The gene discussed is AHR; the disease is colitis.